Perspective Therapeutics Inc (AMEX: CATX) kicked off on Tuesday, down -7.42% from the previous trading day, before settling in for the closing price of $3.1. Over the past 52 weeks, CATX has traded in a range of $1.60-$12.90.
Healthcare Sector giant saw their annual sales slid by -9.86% over the last five years. While this was happening, its average annual earnings per share was recorded 3.61%. With a float of $60.73 million, this company’s outstanding shares have now reached $74.26 million.
The firm has a total of 140 workers. Let’s measure their productivity.
Perspective Therapeutics Inc (CATX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 18.23%, while institutional ownership is 66.81%. The most recent insider transaction that took place on Mar 28 ’25, was worth 49,384. In this transaction Chief Executive Officer of this company bought 22,026 shares at a rate of $2.24, taking the stock ownership to the 59,383 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 4,650 for $2.21, making the entire transaction worth $10,288. This insider now owns 4,650 shares in total.
Perspective Therapeutics Inc (CATX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.21 earnings per share (EPS), lower than consensus estimate (set at -0.2) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.37% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Take a look at Perspective Therapeutics Inc’s (CATX) current performance indicators. Last quarter, stock had a quick ratio of 15.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 171.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Analysing the last 5-days average volume posted by the [Perspective Therapeutics Inc, CATX], we can find that recorded value of 1.49 million was better than the volume posted last year of 0.99 million. As of the previous 9 days, the stock’s Stochastic %D was 6.25%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 1.56%, which indicates a significant increase from 1.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.47 in the past 14 days, which was higher than the 0.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.53, while its 200-day Moving Average is $3.16. Now, the first resistance to watch is $3.04. This is followed by the second major resistance level at $3.20. The third major resistance level sits at $3.31. If the price goes on to break the first support level at $2.77, it is likely to go to the next support level at $2.66. Now, if the price goes above the second support level, the third support stands at $2.50.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
The company with the Market Capitalisation of 213.13 million has total of 74,263K Shares Outstanding. Its annual sales at the moment are 1,450 K in contrast with the sum of -79,280 K annual income. Company’s last quarter sales were recorded 290 K and last quarter income was -21,490 K.
